2-methylimidazole

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1966

Report date:

1966

Materials and methods

Test guideline

Qualifier:

equivalent or similar to guideline

Guideline:

OECD Guideline 401 (Acute Oral Toxicity)

Principles of method if other than guideline:

BASF-Test: The study was conducted according to an internal BASF method which in principle is comparable to the OECD Guideline 401. A test group consisting of 5 animals/sex was treated by single gavage application with an aqueous solution of the test substance. The animals were observed for mortality and for clinical symptoms of toxicity. At the end of the observation period of 14 days, the surviving animals were sacrificed for the purpose of necropsy; animals that died during the observations period also were subjected to necropsy.

GLP compliance:

no

Test type:

standard acute method

Limit test:

no

Test material

Test material information

Constituent 1

Reference substance name:

2-methylimidazole

EC Number:

211-765-7

EC Name:

2-methylimidazole

Cas Number:

693-98-1

Molecular formula:

C4H6N2

IUPAC Name:

2-methyl-1H-imidazole

Details on test material:

- Name of test material (as cited in study report): 2-Methylimidazol

Test animals

Species:

rat

Strain:

other: US-rats

Sex:

male/female

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

water

Details on oral exposure:

VEHICLE
- Concentration in vehicle: 2-20% solution

Doses:

200, 400, 800, 1250, 1600, 2000 and 2500 mg/kg bw

No. of animals per sex per dose:

5

Control animals:

no

Details on study design:

- Duration of observation period following administration: 7 days
- Frequency of observations and weighing: 1, 24 and 48 hours and day 7
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs and body weight

Results and discussion

Effect levels

Sex:

male/female

Dose descriptor:

LD50

Effect level:

ca. 1 500 mg/kg bw

Based on:

test mat.

Mortality:

200 to 800 mg/kg bw group: no deaths occurred
1250 mg/kg group: 6/10 animals died
1600 mg/kg bw group: 5/10 animals died
2000 mg/kg bw group: 9/10 animals died
2500 mg/kg bw group: 8/10 animals died

Clinical signs:

other: Slight shivering, dyspnea and slight swaggering

Gross pathology:

No abnormal observations were reported.